Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
出版年份 2017 全文链接
标题
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
作者
关键词
Cost-effectiveness analysis, Glucagon-like peptide 1, Sodium-glucose transporter 2, Type 2 diabetes mellitus
出版物
Diabetes Therapy
Volume 8, Issue 3, Pages 513-530
出版商
Springer Nature
发表日期
2017-03-27
DOI
10.1007/s13300-017-0250-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
- (2015) M. L. Alva et al. DIABETIC MEDICINE
- Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus: An Analysis from the UK NHS Perspective
- (2015) M Charokopou et al. VALUE IN HEALTH
- Evaluating the Cost-Effectiveness of GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the UK
- (2015) D Ashley et al. VALUE IN HEALTH
- Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway
- (2015) Pernilla Huetson et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
- (2014) Charalampos Tzanetakos et al. BMC HEALTH SERVICES RESEARCH
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes Mellitus
- (2014) Lesley J. Scott DRUGS
- Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries
- (2014) Jørgen T. Lauridsen et al. QUALITY OF LIFE RESEARCH
- Validation of the IMS CORE Diabetes Model
- (2014) Phil McEwan et al. VALUE IN HEALTH
- Review of Utility Values for Economic Modeling in Type 2 Diabetes
- (2014) Amélie Beaudet et al. VALUE IN HEALTH
- Self-Reported Frequency and Impact of Non-Severe Hypoglycaemia in Insulin-Treated Adults in the UK
- (2014) B. Chubb et al. VALUE IN HEALTH
- Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
- (2014) Victoria Divino et al. Diabetes Therapy
- Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
- (2013) H. J. Lambers Heerspink et al. DIABETES OBESITY & METABOLISM
- Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries
- (2013) Marc Evans et al. Health and Quality of Life Outcomes
- The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m2in Spain
- (2013) Tiago Fonseca et al. JOURNAL OF MEDICAL ECONOMICS
- Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs
- (2012) N. Hex et al. DIABETIC MEDICINE
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
- (2011) M. J. Davies et al. DIABETIC MEDICINE
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
- (2010) Clifford J Bailey et al. LANCET
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
- (2010) Richard E Pratley et al. LANCET
- Cost-effectiveness of insulin analogues for diabetes mellitus
- (2009) C. G. Cameron et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started